Mal-PEG4-VC-PAB-DMEA omerine-d3 InChi: InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8

InChi: InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8

The latency to fall in animals treated with WWL70 at 5 mg/kg increases from 74

which is 10- and 44-fold lower than those for paritaprevir and grazoprevir

a selective PAR1 antagonist

Mal-PEG4-VC-PAB-DMEA omerine-d3 InChi: InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8Mal PEG4 VC PAB DMEA is a cleavable ADC linker containing a Maleimide group. Mal PEG4 VC PAB DMEA is used in the synthesis of antibody drug conjugates (ADCs). Product information CAS Number: 1569261 93 3 Molecular Weight: 892. 01 Formula: C41H65N9O13 Chemical Name: {4 [(2S) 5 (carbamoylamino) 2 [(2S) 2 {1 [3 (2,5 dioxo 2,5 dihydro 1H pyrrol 1 yl)propanamido] 3,6,9,12 tetraoxapentadecan 15 amido} 3 methylbutanamido]pentanamido]phenyl}methyl N methyl N